Reneo Pharma Promising Potential For PPAR Agonist, Pending ... - Seeking Alpha
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Reneo |
Reneo Pharma Promising Potential For PPAR Agonist, Pending ... Seeking Alpha
Read at news.google.com
 |
Reneo Pharmaceuticals Fundamental Analysis
We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Reneo Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Reneo Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reneo Pharmaceuticals Related Equities
| CNSP | Cns Pharmaceuticals | 5.45 | ||||
| PRME | Prime Medicine, | 5.07 | ||||
| CGEM | Cullinan Oncology | 3.99 | ||||
| CELC | Celcuity LLC | 2.79 | ||||
| CCCC | C4 Therapeutics | 2.58 | ||||
| NKTX | Nkarta | 2.55 | ||||
| KZR | Kezar Life | 2.13 | ||||
| HOWL | Werewolf Therapeutics | 1.95 | ||||
| RPRX | Royalty Pharma | 0.87 | ||||
| ADPT | Adaptive Biotechnologies | 0.00 | ||||
| SMMT | Summit Therapeutics | 0.00 | ||||
| LEGN | Legend Biotech | 0.06 | ||||
| HEPA | Hepion Pharmaceuticals | 0.20 | ||||
| VIR | Vir Biotechnology | 0.41 | ||||
| IMMX | Immix Biopharma | 0.92 | ||||
| DNA | Ginkgo Bioworks | 0.95 | ||||
| APLS | Apellis Pharmaceuticals | 1.11 | ||||
| EWTX | Edgewise Therapeutics | 1.20 | ||||
| KRON | Kronos Bio | 3.16 | ||||
| OCEA | Ocean Biomedical | 3.22 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |